Key result
Catheter thrombus fragmentation plus fibrinolysis yields 100% clinical success in acute pulmonary embolism.
Why the study?
The effectiveness and safety of combined catheter thrombus fragmentation and fibrinolysis for acute pulmonary embolism with right ventricular dysfunction were evaluated.
Does combined catheter thrombus fragmentation and urokinase injection improve hemodynamics and clinical outcomes in patients with acute pulmonary embolism and right ventricular dysfunction?
Observational (n=46)
Does combined catheter thrombus fragmentation and urokinase injection improve hemodynamics and clinical outcomes in patients with acute pulmonary embolism and right ventricular dysfunction?
Combined catheter thrombus fragmentation and local urokinase injection significantly improved hemodynamics and oxygenation in patients with acute PE and right ventricular dysfunction, with no major complications.
Answers are grounded in this paper and cite their sources.
May support catheter-based therapy in acute PE with RV dysfunction; hypothesis-generating and requires prospective validation before practice change.
AIMS: The aim of this study is to evaluate the effectiveness and safety of combined catheter thrombus fragmentation and fibrinolysis for acute pulmonary embolism (PE). METHODS: Forty-six patients (19 men and 27 women, average age 52.3 ± 13.4 years) with acute PE and right ventricular dysfunction were treated by mechanical thrombus fragmentation with a percutaneous transluminal coronary angioplasty guide catheter. Urokinase was injected into the culprit pulmonary artery after catheter thrombus fragmentation in all patients. RESULT: Clinical success was achieved in all patients. After the treatment, the average pulmonary artery pressure was decreased from 57.2 ± 6.2 to 36.3 ± 4.1 mmHg (P < 0.01). The oxygen saturation rate was raised from 81.4 ± 4.3% to 97.0 ± 2.0% (P < 0.01), and the right ventricular function was improved. There was no in-hospital mortality and there were no major complications, such as haemorrhage. Patients were treated with warfarin for 6 months with no signs of PE recurrence during the follow up. CONCLUSION: In PE patients with right ventricular dysfunction and unstable haemodynamics, combined catheter thrombus fragmentation and thrombolysis appears to be a useful therapeutic strategy. In PE patients with right ventricular dysfunction and stable haemodynamics, randomized trials are still required to show that combination of catheter-directed thrombus fragmentation and thrombolysis is superior to standard anticoagulation.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2011) conducted an observational in Acute pulmonary embolism with right ventricular dysfunction (n=46). Combined catheter thrombus fragmentation and fibrinolysis was evaluated on Clinical success. Combined catheter thrombus fragmentation and fibrinolysis achieved 100% clinical success and decreased average pulmonary artery pressure from 57.2 to 36.3 mmHg in acute pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: